Gynecologic oncologyHumansFemaleMiddle AgedImmune Checkpoint InhibitorsRetrospective Studies
Immune checkpoint inhibitors for recurrent ovarian clear cell carcinoma: Real-world outcomes from a Korean multicenter study.
Young Eun Chung, Se Ik Kim, Joseph J Noh, Jung-Yun Lee, Yong Jae Lee
Published: 202510.1016/j.ygyno.2025.10.040
Abstract
BACKGROUND: Recurrent ovarian clear cell carcinoma (OCCC) is an aggressive, chemotherapy-resistant subtype with poor prognosis. Given its distinct biology, immune checkpoint inhibitors (ICIs) may offer therapeutic potential. This study aimed to asses…
Preview only. Read the full abstract at the source